drugset
drugset / Trial / NCT01151176

Feasible Insulin Algorithm for Glycemic Control in Patients With Acute Coronary Syndrome

NCT01151176 ↗

Phase 4 Suspended 130 enrolled Universidade Positivo Emory University · collab
RandomizedParallel-groupOpen-labelTreatment

Summary

The study aims to demonstrate that a simple intravenous insulin algorithm can be implemented in Latin America and will result in safe and better glucose control in patients with Acute Coronary Syndrome (ACS) compared with SC insulin.

Timeline

Start
2012-08
Primary completion
2013-08
Completion
2013-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Insulin Protein / enzyme biologic 1.8 iu Intravenous
Subject Insulin Protein / enzyme biologic 4 iu Intravenous
Subject Insulin Protein / enzyme biologic 6 iu Intravenous
Subject Insulin Protein / enzyme biologic 8 iu Intravenous
Subject Insulin Protein / enzyme biologic 10 iu Intravenous
Subject Insulin Protein / enzyme biologic 12 iu Intravenous
Subject Insulin Protein / enzyme biologic 14 iu Intravenous
Subject Insulin Protein / enzyme biologic 16 iu Intravenous

Indications

acute coronary syndrome